Fundraising Fox
🦊/Companies
Sign in

Cellbyte

YC W22

Munich, DE · Founded 2024 · 3 employees · 5 known investors

Find your way into Cellbyte

526 people in our graph share verified history with the Cellbyte team — schools, employers, funds. One of them is your warm intro.

Arhaan A.unlockedknows Felix Steinbrenner · together at Y Combinator (overlapped)
×11knows the team · via Y Combinator

Cellbyte automates regulatory workflows and data analysis for pharmaceutical drug launches, helping manufacturers prepare treatments for global markets faster.

Also known as Glocally

AI & Machine LearningEnterprise SoftwareHealthtechMedical DevicesSaaSArtificial IntelligenceData ScienceHealthcare ITGermanyEurope

Founders & leadership· Y Combinator alumni (W22)

Cellbyte was founded in 2024 by Felix Steinbrenner, Daniel, and Samuel.

FSFelix Steinbrenner
Felix SteinbrennerinCo-Founder & Co-CEOFelix Steinbrenner is co-founder and CEO of Cellbyte, an AI agents company focused on pharmaceutical drug development and commercialization. He previously co-founded and led operations at Glocally (Y Combinator W22), an electric vehicle-based same-day delivery service for e-commerce brands.
D
Daniel
S
Samuel

Investors · 5

Frontline VenturesSan Francisco · $540K – $3.2M
Pace VenturesBerlin · $550K – $1.6Mvia Marius Swart · inferred
Y CombinatorSan Francisco · $500K
SARAS CAPITALreportedCanterbury
Springboard Health AngelsreportedBerlin

Funding

SEC filings, press & company announcements

$2.8M disclosed across 1 of 2 rounds · 2025

Source: company announcements and press reports — follow each round's link for the claim.

Competitors · 3

by search overlap
Airbyte4 shared keywordsAirbyte provides a context layer for agents and pipelines, enabling data connectivity and integration solutions. The platform serves organizations that need to connect and manage data across their systems.
Cellectar Biosciences3 shared keywordsCellectar Biosciences is a clinical-stage oncology company developing targeted cancer therapies using its proprietary PLE (phospholipid ether) delivery platform, which delivers therapeutic payloads directly to cancer cells. It focuses on advanced cancers with high unmet needs, including work related to triple-negative breast cancer.
HighByte3 shared keywordsHighByte builds the HighByte Intelligence Hub, an industrial DataOps software product that solves data architecture and integration problems for manufacturing and industrial operations. It serves manufacturers and industrial end users, connecting operational and enterprise systems.

Companies competing with Cellbyte for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Cellbyte Raises $2.75 Million | Function Health Announces $298M Oversubscribed Series B | Arbiter Emerges from Stealth with $52M | Healthcare IT Todayhealthcareittoday.com · Dec 2025Cellbyte raises $2.75m to fund pharma drug launch platform - Pharmafilepharmafile.com · Nov 2025Startup in spotlight: Cellbyte zips $2.75M to cut pharma drug launch times — TFNtechfundingnews.com · Nov 2025Cellbyte raises $2.75m to slash drug launch timelines with AI - PharmaTimespharmatimes.com · Nov 2025Cellbyte Raises $2.75M to Accelerate Drug Launches with AI-Native Platform -hitconsultant.net · Nov 2025Cellbyte Raises $2.75M in Seed Fundingfinsmes.com · Nov 2025Cellbyte - AI Agents for Pharma Drug Launchesycombinator.com · Aug 2024

Frequently asked questions

What does Cellbyte do?
Cellbyte automates regulatory workflows and data analysis for pharmaceutical drug launches, helping manufacturers prepare treatments for global markets faster.
Who founded Cellbyte?
Cellbyte was founded by Felix Steinbrenner, Daniel, Samuel in 2024.
Who are Cellbyte's investors?
Cellbyte's investors include Frontline Ventures, Pace Ventures, Y Combinator, SARAS CAPITAL, Springboard Health Angels.
How much funding has Cellbyte raised?
Cellbyte has disclosed $2.8M raised across 1 of its 2 known rounds.
Where is Cellbyte headquartered?
Cellbyte is headquartered in Munich, DE.